Cardiac Ambulatory Monitoring Market Report 2026

Cardiac Ambulatory Monitoring Market Overview

• Cardiac Ambulatory Monitoring market size has reached to $14.93 billion in 2025 • Expected to grow to $19.45 billion in 2030 at a compound annual growth rate (CAGR) of 5.4% • Growth Driver: Rising Cardiovascular Disease Drives Growth In Cardiac Ambulatory Monitoring • Market Trend: Innovations In Cardiac Ambulatory Monitoring Technologies • North America was the largest region in 2025.

What Is Covered Under Cardiac Ambulatory Monitoring Market?

Cardiac ambulatory monitoring refers to the continuous recording and assessment of a patient's heart activity while they go about their daily activities outside a clinical setting. This monitoring is often used to detect arrhythmias, evaluate the effectiveness of cardiac treatments, and assess overall heart health over an extended period. The main types of cardiac ambulatory monitoring are electrocardiogram (ECG) devices, holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry. Electrocardiogram (ECG) devices refer to medical instruments used to measure and record the electrical activity of the heart, providing essential data for diagnosing cardiac conditions. There are specialties in this field, including single specialty and multi-specialty practices. The end users of these monitoring devices include hospitals, ambulatory surgical centers, specialty clinics, cardiac care centers, and home care settings.

What Is The Cardiac Ambulatory Monitoring Market Growth Forecast?

The cardiac ambulatory monitoring market size is expected to see strong growth in the next few years. It will grow to $19.45 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to increasing integration of ai-assisted rhythm analysis, growing demand for telecardiology services, expansion of home healthcare monitoring, rising use of mobile cardiac telemetry, increasing adoption of digital health platforms. Major trends in the forecast period include increasing adoption of long-term wearable monitoring devices, rising demand for home-based cardiac monitoring, growing use of wireless and patch-based ecg systems, expansion of continuous remote arrhythmia detection, enhanced focus on patient comfort and compliance.

Global Cardiac Ambulatory Monitoring Market Segmentation

1) By Product: Electrocardiogram (ECG) Devices, Holter Monitors, Event Monitors, Implantable Loop Recorders, Mobile Cardiac Telemetry 2) By Specialty: Single Specialty, Multi-Specialty 3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Cardiac Care Centers, Home Care Setting Subsegments: 1) By Electrocardiogram (ECG) Devices: Portable ECG Monitors, Wireless ECG Monitors, Smartphone-based ECG Devices 2) By Holter Monitors: 24-hour Holter Monitors, 48-hour Holter Monitors, 72-hour Holter Monitors 3) By Event Monitors: Wireless Event Monitors, Wearable Event Monitors 4) By Implantable Loop Recorders: Standard Implantable Loop Recorders, Long-term Implantable Loop Recorders 5) By Mobile Cardiac Telemetry: Continuous Mobile Telemetry Systems, Patch-based Mobile Telemetry Systems

What Is The Driver Of The Cardiac Ambulatory Monitoring Market?

The rising prevalence of cardiovascular disease is expected to propel the growth of the cardiac ambulatory monitoring market going forward. Cardiovascular disease (CVD) refers to a group of disorders affecting the heart and blood vessels, including conditions such as heart attacks, strokes, and heart failure. These diseases typically arise from blockages in blood vessels or abnormalities in heart function. The prevalence of cardiovascular disease is due to factors such as unhealthy diets, lack of exercise, smoking, stress, and an aging population. Additionally, conditions such as obesity, diabetes, and hypertension are contributing to its growing prevalence. Cardiac ambulatory monitoring allows for continuous heart activity tracking, helping detect irregularities early in cardiovascular disease patients. It aids in managing heart conditions more effectively by enabling real-time diagnosis and monitoring without needing constant hospital visits. For instance, in September 2024, according to the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million individuals are currently affected by heart and circulatory diseases, comprising 4 million men and 3.6 million women. By 2030, this number could increase by 1 million, and by 2040, it may rise to 2 million more than the current figures. Therefore, the prevalence of cardiovascular disease is driving the growth of the cardiac ambulatory monitoring industry.

Key Players In The Global Cardiac Ambulatory Monitoring Market

Major companies operating in the cardiac ambulatory monitoring market are Abbott Laboratories, Medtronic PLC, Koninklijke Philips N.V., GE Healthcare, Boston Scientific Corporation, Biotronik SE & Co. KG, Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., Schiller AG, iRhythm Technologies Inc., ZOLL Medical Corporation, Medicomp Inc., AliveCor Inc., QT Medical Inc., InfoBionic Inc., VivaLNK Inc., Cardiomo Inc., WebCardio LLC, Applied Cardiac Systems, ACS Diagnostics Inc.

Global Cardiac Ambulatory Monitoring Market Trends and Insights

Major companies operating in the cardiac ambulatory monitoring market are focused on developing innovative technologies, such as artificial intelligence (AI) and Bluetooth connectivity electrocardiogram devices, to enhance patient monitoring and data accuracy. Artificial intelligence (AI) and Bluetooth connectivity electrocardiogram devices refer to advanced medical tools that leverage AI algorithms for real-time analysis of heart data and use Bluetooth technology to transmit this information wirelessly to healthcare providers. For instance, in September 2024, AliveCor Inc., a US-based company that provides remote cardiac care services, launched the KardiaMobile Card to give users a convenient, portable tool for real-time heart monitoring, particularly for detecting arrhythmias and managing heart conditions directly from their wallet. It makes real-time heart health data easily accessible to patients, enabling early detection of heart issues and helping to reduce the economic burden of cardiovascular diseases.

What Are Latest Mergers And Acquisitions In The Cardiac Ambulatory Monitoring Market?

In May 2024, WearLinq Inc., a US-based company that provides wearable health monitoring and diagnosis solutions, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. This strategic acquisition will enhance WearLinq's nationwide clinical services and expand access to its FDA-cleared eWave 6-lead wearable ECG monitor, improving cardiac diagnostics and positioning the company as a market leader. Cardiac Monitoring LLC is a US-based independent diagnostic testing facility for ambulatory cardiac monitoring.

Regional Outlook

North America was the largest region in the cardiac ambulatory monitoring market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cardiac Ambulatory Monitoring Market?

The cardiac ambulatory monitoring market consists of revenues earned by entities by providing services such as holter monitoring, patch electrocardiogram monitoring, mobile cardiac telemetry (MCT), and wireless remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac ambulatory monitoring market also includes sales of remote patient monitoring systems, wearable fitness trackers, and cardiac rehabilitation monitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cardiac Ambulatory Monitoring Market Report 2026?

The cardiac ambulatory monitoring market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac ambulatory monitoring industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.